
|Articles|May 2, 2004
- Pharmaceutical Technology-05-02-2004
- Volume 28
- Issue 5
FDA Eyes Manufacturing Innovation to Boost Drug Development
Author(s)Jill Wechsler
New technologies, along with changes in FDA oversight, may provide a critical path to make more new drugs available more quickly to patients.
Advertisement
Articles in this issue
about 22 years ago
In The Spotlight-May 2004about 22 years ago
Prepare for Bar Codingabout 22 years ago
aaiPharma Situation Underscores The Need for Due Diligenceabout 22 years ago
Excipient Functionalityabout 22 years ago
May 2004Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Hold Times in Biopharmaceuticals
2
Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet
3
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
4
Merck KGaA Launches Saturnus Bio; Announces Awards
5




